Skip to main
LGND
LGND logo

Ligand Pharmaceuticals (LGND)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Ligand Pharmaceuticals (LGND) Stock

About Ligand Pharmaceuticals (LGND)

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
Market cap$2.19B
Yesterday's volume111.38K
Revenue (TTM)$181.49M
Avg. daily volume123.49K
EBITDA (TTM)$20.86M
Open$115.38
Price / earnings ratio-15.97x
Yesterday's range$113.27 - $115.38
Debt / equity0.56x
52 week range$81.74 - $129.9
5 year debt / equity21.14x
Beta (LTM)1.04x
Interest coverage7.58x
Dividend & yield$0.00 (0.00%)
Current ratio5.27x
Ex-dividend date
Next earningsAug 5, 2025
Dividend payable date

Ligand Pharmaceuticals Stock Rating

What analysts recommend for LGND stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 44%
Buy 28%
Hold 22%
Sell 0%
Strong Sell 6%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for LGND stock is $2.2B

The current P/E ratio for LGND stock is -15.97

The 52-week high for LGND stock is $129.90. The current LGND stock price $undefined is 100.00% below its 52-week high

The 52-week low for LGND stock is $81.74. The current LGND stock price $undefined has increased 100.00% from its 52-week low

No, the LGND stock does not pay dividends to its shareholders

The target price for LGND stock is $128.50 based on the average of what a group of analyst think LGND stock could be worth at a future date. This is not a prediction by Public.com

How to buy LGND stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in LGND stock

    Navigate to the Explore page. Then, type LGND into the search bar. When you see LGND stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased LGND stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Ligand Pharmaceuticals Stock Earnings

The value each LGND share was expected to gain vs. the value that each LGND share actually gained.

Ligand Pharmaceuticals (LGND) reported Q1 2025 earnings per share (EPS) of $1.33, beating estimates of $1.21 by 9.92%. In the same quarter last year, Ligand Pharmaceuticals's earnings per share (EPS) was $3.84. Ligand Pharmaceuticals is expected to release next earnings on 08/05/2025, with an earnings per share (EPS) estimate of $0.

Buy Ligand Pharmaceuticals (LGND) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.